Published on
August 12, 2026
- 12:00 GMT
PulmoSIM Therapeutics Secures Foundational U.S. Patent Allowance for PT001
Notice of Allowance strengthens PulmoSIM's therapeutic portfolio while validating VeriSIM Life's platform for advancing therapeutics from design to the clinic. SAN FRANCISCO, CA, UNITED STATES, August 12, 2026 /EINPresswire.com/ -- PulmoSIM …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
